Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates

Journal of Medical Microbiology

Volumn 53, Issue 11, 2004, Pages 1145-1149

  Mundy, Rosanna ^a   Jenkins, Claire ^b   Yu, Jun ^a   Smith, Henry ^c   Frankel, Gad ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; EFFECTOR PROTEIN; ESP PROTEIN; INTIMIN; NLEA PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL TRANSLOCATION; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; DIARRHEA; DISEASE SEVERITY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI; ESPL GENE; GENE LOCUS; GRAM NEGATIVE INFECTION; HUMAN; LEE PATHOGENICITY ISLAND; NONHUMAN; PRIORITY JOURNAL; PROPHAGE; PROTEIN ANALYSIS; SECRETION; TYPE III SECRETION APPARATUS;

ADHESINS, BACTERIAL; ANTIGENS, BACTERIAL; DIARRHEA; EPIDEMIOLOGY, MOLECULAR; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; GENOMIC ISLANDS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; LONDON; O ANTIGENS; PROPHAGES; SEROTYPING; VIRULENCE FACTORS;

EID: 11144231319     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45684-0     Document Type: Article

References (29)

1. Caprioli, A., Tozzi, A. E., Rizzoni, G. & Karch, H. (1997). Non-O157 Shiga toxin-producing Escherichia coli infections in Europe. Emerg Infect Dis 3, 578-579.
2. Dougan, G., Haque, A., Pickard, D., Frankel, G., O'Goara, P. & Wain, J. (2001). The Escherichia coli gene pool. Curr Opin Microbiol 4, 90-94.
3. Elliott, S. J., Krejany, E. O., Mellies, J. L., Robins-Browne, R. M., Sasakawa, C. & Kaper, J. B. (2001). EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri. Infect Immun 69, 4027-4033.
4. Evans, J., Wilson, A., Willshaw, G. A., Cheasty, T., Tompkins, D. S., Wheeler, J. G. & Smith, H. R. (2002). Vero cytotoxin-producing Escherichia coli in a study of infectious intestinal disease in England. Clin Microbiol Infect Dis 8, 183-186.
5. Frankel, G., Phillips, A. D., Rosenshine, I., Dougan, G., Kaper, J. B. & Knutton, S. (1998). Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol Microbiol 30, 911-921.
6. Gruenheid, S., Sekirov, I., Thomas, N. A. & 10 other authors (2004). Identification and characterization of NleA, a non-LEE encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7. Mol Microbiol 51, 1233-1249.
7. Hayashi, T., Makino, K., Ohnishi, M. & 19 other authors (2001). Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. DNA Res 28, 11-22.
8. Jenkins, C., Lawson, A. J., Cheasty, T., Willshaw, G. A., Wright, P., Dougan, G., Frankel, G. & Smith, H. R. (2003a). Subtyping intimin genes from enteropathogenic Escherichia coli associated with outbreaks and sporadic cases in the United Kingdom and Eire. Mol Cell Probes 17, 149-156.
9. Jenkins, C., Perry, N., Cheasty, T. & 7 other authors (2003b). Distribution of the saa gene in strains of Shiga toxin-producing Escherichia coli of human and bovine origin. J Clin Microbiol 41, 1775-1778.
10. Jenkins, C., Willshaw, G. A., Evans, J., Cheasty, T., Chart, H., Shaw, D. J., Dougan, G., Frankel, G. & Smith, H. R. (2003c). Subtyping of virulence genes in verocytotoxin-producing Escherichia coli (VTEC) other than serogroup 0157 associated with disease in the United Kingdom. J Med Microbiol 52, 941-947.
11. Jerse, A. E., Yu, J., Tall, B. D. & Kaper, J. B. (1990). A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 87, 7839-7843.
12. Kenny, B. & Jepson, M. (2000). Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria. Cell Microbiol 2, 579-590.
13. Kenny, B., DeVinney, R., Stein, M., Reinscheid, D. J., Frey, E. A. & Finlay, B. B. (1997). Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91, 511-520.
14. Kleanthous, H., Smith, H. R., Scotland, S. M., Gross, R. J., Rowe, B., Taylor, C. M. & Milford, D. V. (1990). Haemolytic uraemic syndromes in the British Isles, 1985-1988: association with verocytotoxin producing Escherichia coli. Part 2: microbiological aspects. Arch Dis Child 65, 722-727.
15. Maniatis, T., Fritsch, E. F. & Sambrook, J. (1982). Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
16. Marches, O., Ledger, T. N., Boury, M. & 8 other authors (2003). Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol 50, 1553-1567.
17. McDaniel,T. K., Jarvis, K. G., Donnenberg, M. S. & Kaper, J. B. (1995). A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci U S A 92, 1664-1668.
18. McNamara, B. P. & Donnenberg, M. S. (1998). A novel proline-rich protein, EspF, is secreted from enteropathogenic Escherichia coli via the type III export pathway. FEMS Microbiol Lett 166, 71-78.
19. Mellies, J. L., Elliott, S. J., Sperandio, V., Donnenberg, M. S. & Kaper, J. B. (1999). The Per regulon of enteropathogenic Escherichia coli: identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)-encoded regulator (Ler). Mol Microbiol 33, 296-306.
20. Mundy, M., Petrovska, L., Smollett, K. & 8 other authors (2004). Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and the roles of this and other secreted proteins in infection. Infect Immun 72, 2288-2302.
21. Nataro, J. P. & Kaper, J. B. (1998). Diarrheagenic Escherichia coli. Clin Microbiol Rev 11, 142-201.
22. Nataro, J. P., Baldini, M. M., Kaper, J. B., Black, R. E., Bravo, N. & Levine, M. M. (1985). Detection of an adherence factor of enteropathogenic Escherichia coli with a DNA probe. J Infect Dis 152, 560-565.
23. Perna, N. T., Plunkett, G., 3rd, Burland, V. & 25 other authors (2001). Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Nature 409, 529-533.
24. Stevens, M. P., van Diemen, P. M., Frankel, G., Phillips, A. D. & Wallis, T. S. (2002). Efa1 influences colonization of the bovine intestine by shiga toxin-producing Escherichia coli serotypes O5 and O111. Infect Immun 70, 5158-5166.
25. Tompkins, D. S., Hudson, M. J., Smith, H. R. & 8 other authors (1999). A study of infectious intestinal disease in England: microbiological findings in cases and controls. Commun Dis Public Health 2, 108-113.
26. Tu, X., Nisan, J., Yona, C., Hanski, E. & Rosenshine, J. (2003). EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol Microbiol 47, 595-606.
27. Wain, J., House, D., Pickard, D., Dougan, G. & Frankel, G. (2001). Acquisition of virulence-associated factors by the enteric pathogens Escherichia coli and Salmonella enterica. Philos Trans R Soc Lond B Biol Sci 356, 1027-1034.
28. Willshaw, G. A., Scotland, S. M., Smith, H. R. & Rowe, B. (1992). Properties of Verocytotoxin-producing Escherichia coli of human origin of O-serogroups other than O157. J Infect Dis 166, 797-802.
29. Willshaw, G. A., Cheasty, T., Smith, H. R., O'Brien, S. J. & Adak, G. K. (2001). Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995 to 1998. J Med Microbiol 50, 135-142.